Introduction

In 1991, James Watson said,

“Many people say they are worried about the changes in our genetic instructions. But these (genetic instructions) are merely a product of evolution, shaped so we can adapt to certain conditions which might no longer exist. We all know how imperfect we are. Why not become a little better apt to survive?”

Since the beginning of life on Earth, humans have understood that the characteristics of our parents can be transmitted to our descendants. How I wish I had my father’s brilliant blue eyes; I have my mother’s eye color! Up until 1950, little was known about the physical nature of genes. Americans James Watson and Francis Crick developed the model of double strand DNA in the 1950’s. In 1970, researchers discovered a series of enzymes that enabled the separation of the genes in predetermined sites along the DNA molecule and their reinsertion in a reproducible manner. These genetic advances enabled the development of new drugs and antibodies utilizing genetic engineering techniques we have on the market today.

We both began our careers in the biotechnology industry working with Monoclonal Antibodies and Biopharmaceutical products which were produced using genetic engineering techniques to “program” bacterial, yeast or mammalian cells to produce monoclonal antibodies or proteins identical to those produced in the human body. Some of the first vaccines, therapies, and diagnostic products using these techniques were approved by the FDA and launched in the US and other global markets in the late 1980s and early 1990s.

In 1980, scientists conceived gene therapy.

… and the rest is history.

Overview

The ability to make local modifications in the human genome has been the objective of Medicine since the knowledge of DNA as the basic unit of heredity. Gene therapy is the capacity for gene improvement/modification by correcting mutated genes or making site-specific modifications in the DNA that have a therapeutic effect.

One of the most often used techniques in gene therapy uses the recombinant DNA techniques developed in the 1980s, in which the gene of interest or healthy gene is inserted into a vector, which can be a plasmid, nanoparticle, or virus; the latter is the most often used due to its ability to invade cells and introduce its genetic material.

The Basics of Gene Therapy

Gene therapy is about altering genes to prevent or treat disease. At its core, it involves replacing, repairing, or reprogramming genetic material within a patient’s cells. This approach can address the root cause of genetic disorders, offering hope for previously untreatable conditions.

One of the fundamental aspects of gene therapy is the delivery of genetic material into cells. This process often uses viral vectors, which have been engineered to safely carry therapeutic genes. Understanding these vectors’ mechanism is crucial, as it determines the therapy’s efficiency and safety.

Recent advancements in gene therapy include the development of nanoparticles that mimic viral vectors. These bioorthogonal engineered (term bioorthogonal chemistry refers to any chemical reaction that can occur inside of living systems without interfering with native biochemical processes.) virus-like recombinant biosomes have shown strong and rapid binding capabilities to LDL receptors on cell surfaces, facilitating efficient gene delivery to specific tissues.

Real-world applications of gene therapy are diverse. From treating hemophilia by introducing functional copies of clotting factor genes to addressing inherited retinal diseases, gene therapy’s impact is profound. These examples highlight its potential to transform the landscape of chronic disease management.

Understanding Gene Therapy

The process typically involves using vectors—often viruses—to deliver the corrected genes into the patient’s cells. These vectors are engineered to be safe and non-pathogenic, ensuring they do not cause disease while effectively introducing therapeutic genetic material. Once inside the cells, the new genes can produce functional proteins to replace or repair faulty ones, thereby addressing the underlying genetic disorder.

For medical professionals, understanding these mechanisms is crucial as it lays the foundation for evaluating the efficacy and safety of various gene therapy approaches. This knowledge enables them to make informed decisions when considering gene therapy as a treatment option for their patients.

Moreover, a solid grasp of vector selection, gene delivery, and long-term effects allows medical professionals to make informed decisions about whether gene therapy is a suitable option for their patients. Such decisions involve considering the patient’s specific condition, the type of vector used, and the potential risks and benefits involved in the treatment.

As gene therapy continues to advance, medical professionals will also play a pivotal role in patient education, helping them understand the potential outcomes and the evolving landscape of these innovative treatments.

The Mechanisms Behind Gene Therapy

Gene therapy relies on several intricate mechanisms to achieve its therapeutic effects. One common method is gene addition, where a functional copy of a gene is introduced into cells to compensate for a defective one. This approach is particularly useful for conditions caused by a lack of specific proteins, such as cystic fibrosis.

Another mechanism is gene correction, which involves directly repairing the faulty gene responsible for a condition. Techniques like CRISPR-Cas9 enable precise gene editing, allowing scientists to target and modify specific DNA sequences within the genome. This level of precision holds promises for treating genetic disorders with pinpoint accuracy.

Gene suppression is yet another mechanism, whereby the expression of a harmful or overactive gene is reduced or silenced. This approach can be beneficial for conditions like Huntington’s disease, where reducing the production of a toxic protein can alleviate symptoms and slow disease progression.

Despite its promise, gene therapy comes with challenges. Safety concerns include immune reactions, potential unintended edits, and long-term effects. Ethical debates also surround gene therapy, especially regarding germline editing, which could impact future generations. Additionally, the cost of gene therapy remains prohibitively high, making access difficult for many patients.

The Regulatory Landscape of Gene Therapy

Navigating the regulatory landscape is crucial for the successful implementation of gene therapy. Medical professionals must stay informed about evolving guidelines and requirements to ensure patient safety and compliance with legal standards.

The FDA has played a pivotal role in overseeing gene therapy trials and approvals. Since the approval of the first gene therapy product, FDA has developed numerous guidelines to evaluate the safety and efficacy of gene therapies, ensuring they meet the highest quality benchmarks.

Please refer to the FDA’s comprehensive Cellular & Gene Therapy Guidance, which date back to 1998, by clicking on the link here.

Ongoing communication between researchers, clinicians, and FDA is essential to streamline the approval process and bring innovative therapies to patients faster.

Contact Us

To learn more about this topic, contact us by filling out the form below.